Cannara Biotech Inc. (LOVFF) Stock Price & Growth Analysis

Quote Panel

Updated October 17, 2025

1W -3.20 % 1M -3.97 % 3M -4.72 % 1Y 154.04 %

Key Metrics

Market Cap
110.63M
Shares Outstanding
91.43M
Share in Float
44.54M
Dividende
0

Earning Date
No Data
Price Target
1.21
Average Volume
4350
Beta
0.215

Range
0.4255-1.42
Industry
Drug Manufacturers - Specialty & Generic
Website
https://cannara.ca
Sector
Healthcare

Quote Panel

Updated October 17, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

10.20x

P/E Ratio

1.52x

P/S Ratio

1.58x

P/B Ratio

0.5

Debt/Equity

15.2%

Net Margin

$0.1

EPS

How LOVFF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

LOVFF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

LOVFF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$167M

509%

2026-Revenue

N/A

2026-EPS

$4M

-152%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.01
vs -0.01

Q2.23

+92%

0.02
vs 0.01

Q3.23

+71%

0.04
vs 0.02

Q4.23

+19%

0.02
vs 0.01

Q1.24

N/A

-0.03
vs -0.01

Q2.24

-34%

0.02
vs 0.02

Q3.24

+23%

0.05
vs 0.04

Q4.24

+5%

0.02
vs 0.02

Q1.25

+188%

0.02
vs -0.03

Q2.25

+79%

0.03
vs 0.02

Sales Growth

YoY

Current

Estimates

Q2.23

+57%

15.8M vs 10.1M

Q3.23

+55%

18.3M vs 11.8M

Q4.23

+89%

19.5M vs 10.3M

Q1.24

+51%

19.7M vs 13M

Q2.24

+23%

19.5M vs 15.8M

Q3.24

+26%

23M vs 18.3M

Q4.24

+29%

25.1M vs 19.5M

Q1.25

+35%

26.6M vs 19.7M

Q2.25

+40%

27.3M vs 19.5M

Q3.25

+37%

31.5M vs 23M

Return on Equity

QoQ

Q1.23

-1%

-0.01
vs 0

Q2.23

+4%

0.04
vs -0.01

Q3.23

+6%

0.06
vs 0.04

Q4.23

+3%

0.03
vs 0.06

Q1.24

-4%

-0.04
vs 0.03

Q2.24

+2%

0.02
vs -0.04

Q3.24

+7%

0.07
vs 0.02

Q4.24

+3%

0.03
vs 0.07

Q1.25

+4%

0.04
vs 0.03

Q2.25

+4%

0.04
vs 0.04

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.01
vs -0.01

Q2.23

+92%

0.02
vs 0.01

Q3.23

+71%

0.04
vs 0.02

Q4.23

+19%

0.02
vs 0.01

Q1.24

N/A

-0.03
vs -0.01

Q2.24

-34%

0.02
vs 0.02

Q3.24

+23%

0.05
vs 0.04

Q4.24

+5%

0.02
vs 0.02

Q1.25

+188%

0.02
vs -0.03

Q2.25

+79%

0.03
vs 0.02

Sales Growth

YoY

Current

Estimates

Q2.23

+57%

15.8M vs 10.1M

Q3.23

+55%

18.3M vs 11.8M

Q4.23

+89%

19.5M vs 10.3M

Q1.24

+51%

19.7M vs 13M

Q2.24

+23%

19.5M vs 15.8M

Q3.24

+26%

23M vs 18.3M

Q4.24

+29%

25.1M vs 19.5M

Q1.25

+35%

26.6M vs 19.7M

Q2.25

+40%

27.3M vs 19.5M

Q3.25

+37%

31.5M vs 23M

Return on Equity

QoQ

Q1.23

-1%

-0.01
vs 0

Q2.23

+4%

0.04
vs -0.01

Q3.23

+6%

0.06
vs 0.04

Q4.23

+3%

0.03
vs 0.06

Q1.24

-4%

-0.04
vs 0.03

Q2.24

+2%

0.02
vs -0.04

Q3.24

+7%

0.07
vs 0.02

Q4.24

+3%

0.03
vs 0.07

Q1.25

+4%

0.04
vs 0.03

Q2.25

+4%

0.04
vs 0.04

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

1.21USD

10.20x

1.52x

1.58x

0.5

15.2%

$0.1

$167M

N/A

$4M

Earnings Growth

Latest News

Latest News

Earnings Growth

Latest News

$167M

N/A

$4M

Company Description

1.21USD

10.20x

1.52x

1.58x

0.5

15.2%

$0.1